Table 1. Study site characteristics.
| Characteristic | Site A | Site B | Site C | Site D | Site E | Site F | Site G | Site H |
|---|---|---|---|---|---|---|---|---|
| Targeted cancer sites | ||||||||
| Breast | X | X | X | X | X | X | X | |
| Cervical | X | X | X | X | ||||
| Colorectal | X | X | X | X | X | |||
| Prostate | X | X | ||||||
| Design | ||||||||
| Randomized—individual level | X | X | ||||||
| Randomized—group level | X | X | ||||||
| Nonrandomized | X | X | X | X | ||||
| Unit of assignment | ||||||||
| Individual | X | X | ||||||
| Group | X | X | X | X | X | X | ||
| Controls | ||||||||
| Actively recruited controls | X | X | X | |||||
| Medical record-based controls | X | X | X | X | X | |||
| Clinics/care sites number (no. of navigated sites/no. of control sites) | 6 (3/3) | 9 (5/4) | 1 | 1 | 16 (8/8) | 11 | 5 (2/3) | 12 (7/5) |
| Background of patient navigators | ||||||||
| Lay | X | X | X | X | X | X | X | X |
| Professional | X | X | X | |||||
| Enrollment as of 1 June 2011 | ||||||||
| Total participants | 3042 | 1023 | 513 | 1249 | 674 | 344 | 1052 | 1320 |
| Participants with cancer | 196 | 118 | 0 | 171 | 27 | 321 | 9 | 53 |